International Conference on Advancements in Obesity Therapies and Diabetes
ICAOTAD
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest advancements in pharmacotherapy for obesity, focusing on novel drug mechanisms and their clinical implications. Researchers are encouraged to present findings on efficacy, safety, and patient adherence to obesity medications.
SDG 3
SDG 4
This session will delve into the intricate metabolic pathways that contribute to diabetes onset and progression. Presentations will highlight recent discoveries in metabolic regulation and their potential therapeutic targets.
SDG 3
SDG 9
This track will examine the effectiveness of behavioral interventions in promoting weight loss and preventing diabetes. Studies on lifestyle modifications, counseling techniques, and community-based programs are particularly welcome.
SDG 2
SDG 3
This session will focus on the emerging role of gut microbiota in the pathophysiology of obesity and diabetes. Researchers are invited to present data on microbiome composition, function, and its implications for therapeutic strategies.
SDG 3
SDG 12
This track will highlight cutting-edge technologies such as wearable devices, mobile health applications, and telemedicine in managing obesity and diabetes. Contributions should address the impact of these innovations on patient outcomes and healthcare delivery.
SDG 3
SDG 9
This session will explore dietary interventions and nutritional strategies aimed at controlling obesity and diabetes. Presentations should focus on evidence-based approaches, including macronutrient composition and meal timing.
SDG 2
SDG 3
This track will investigate the psychosocial determinants of obesity and diabetes, including stress, depression, and social support. Research on the interplay between mental health and metabolic disorders is encouraged.
SDG 3
SDG 10
This session will address the growing epidemic of pediatric obesity and its implications for diabetes risk. Contributions should focus on prevention strategies, treatment modalities, and the role of schools and communities.
SDG 3
SDG 4
This track will examine the disparities in obesity and diabetes prevalence and outcomes across different populations. Research addressing social determinants of health and strategies to reduce inequities is highly encouraged.
SDG 1
SDG 10
This session will focus on the latest advancements in bariatric surgery for obesity treatment. Presentations should include surgical techniques, patient selection criteria, and long-term outcomes.
SDG 3
SDG 9
This track will explore integrative and holistic approaches to managing obesity and diabetes, including complementary therapies and lifestyle interventions. Research on the efficacy of these approaches in clinical practice is welcomed.
SDG 3
SDG 4